Govt to companies: stop selling drugs

    The Food and Drug Administration has told two Pennsylvania companies to stop making unapproved narcotics.

    Two pharmaceutical companies in Pennsylvania are in hot water for selling unapproved narcotics. From WHYY’s health and science desk, Kerry Grens reports. (Photo: Michelle Tribe)

    Listen: [audio:sci20090401drugs.mp3]

    Get the mp3 »

    • WHYY thanks our sponsors — become a WHYY sponsor

     

    Transcript:

    The Food and Drug Administration sent letters to Lannett Company in Philadelphia and Lehigh Valley Technologies in Bethlehem this week. They are among a number of companies that make morphine medications and other pain killers not approved by the FDA. Michael Levy is the director of the division of new drugs and labeling compliance at the FDA. He says this is the latest move to get thousands of unapproved drugs off pharmacy shelves.

    Levy: We estimated when we began this initiative in 2006 that approximately 2% of all prescriptions are filled for unapproved drugs.

    If the companies don’t comply by ceasing to market the medications, they could face criminal penalties. The manufacturers have 60 days to stop making the pain killers. Both Lannett and Lehigh Valley Technologies did not respond to requests for comment.

    WHYY is your source for fact-based, in-depth journalism and information. As a nonprofit organization, we rely on financial support from readers like you. Please give today.

    Want a digest of WHYY’s programs, events & stories? Sign up for our weekly newsletter.

    Together we can reach 100% of WHYY’s fiscal year goal